💡 Overview & Quick Summary
Prasol Chemicals Limited IPO Summary: Prasol Chemicals Limited is launching its Initial Public Offering (IPO) of ₹500.00 Crore (Fresh Issue: ₹80.00 Cr; OFS: ₹420.00 Cr for 73,96,437 equity shares) priced in a band of ₹643 to ₹676 per share (Face Value: ₹2/-), open from September 8 to September 10, 2026. Incorporated in 1992 with over 33 years of experience, the company is India's largest importer of acetone (CY2022-2025) and India's sole manufacturer of isophorone, producing 150+ specialty chemical products exported to 69 countries. Total income expanded to ₹1,237.85 Cr in FY26 (up 21.9% YoY) with PAT surging 90.7% to ₹83.12 Cr and RoNW strengthening to 18.53%. Sushil Finance assigns a Subscribe recommendation based on operating leverage, margin expansion, clean capital efficiency gains, and strong structural pricing power.
1. IPO Overview
Prasol Chemicals Limited has announced its Initial Public Offering (IPO) parameters. The issue opens for subscription on September 8, 2026, and closes on September 10, 2026. The price band has been fixed at ₹643 to ₹676 per equity share with a face value of ₹2/- per share. The offer aggregates up to ₹500.00 crore comprising 73,96,437 equity shares.
| Issue Parameter |
Details |
| Price Band |
₹643 to ₹676 Per Share |
| Issue Opens on |
Sep 8, 2026 |
| Issue Closes on |
Sep 10, 2026 |
| Lot Size |
22 Shares & in Multiples thereafter |
| Issue Size |
₹500.00 cr. |
| No. of Shares |
73,96,437 |
| Face Value |
₹2/- |
| Listing Stock Exchanges |
BSE & NSE |
| Lead Managers |
Dam Capital Advisors Ltd. |
| Registrar to the Issue |
Kfin Technologies Ltd |
2. Key IPO Details & Offer Structure
The ₹500.00 crore public offering is structured into a fresh issuance of equity shares by the company and an Offer for Sale (OFS) by selling shareholders. The reservations and allocations across Qualified Institutional Buyers (QIB), High Net-Worth Individuals / Non-Institutional Investors (HNI), and Retail Individual Investors are summarized below:
Offer Structure
| Issuance |
in Cr. |
| Fresh Issue |
80.00 |
| Offer for Sale |
420.00 |
| Total |
500.00 |
Issue Breakup by Investor Category
| Reservation for |
% of Issue |
in Cr. (at upper band) |
| QIB |
50% |
250.00 |
| HNI |
15% |
75.00 |
| RETAIL |
35% |
175.00 |
| TOTAL |
100% |
500.00 |
3. Company Overview
Prasol Chemicals Limited, incorporated in 1992, is a forward-integrated manufacturer of acetone- and phosphorous-based specialty chemicals with over 33 years of industry experience, involving complex and differentiated chemistries.
According to the CARE Report, the Company is a highly diversified specialty chemical player with over 150 specialty chemical products, serving more than 1,600 customers and exporting to 69 countries as of July 15, 2026.
Its product portfolio spans three broad categories:
- 21 acetone-based specialty chemicals
- 53 phosphorous-based specialty chemicals
- 76 other specialty products (including surfactants, performance additives, ethers, esters, polymers and acids)
These product categories address five key end-use segments:
- Performance chemicals (lubricant additives, mining chemicals)
- PICA (paints, inks, construction and adhesives)
- Pharmaceuticals
- Agrochemicals
- Home and personal care
Prasol was India's largest importer of acetone, using it to produce the country's most diversified range of acetone-based specialty chemicals including diacetone alcohol, isophorone (of which it is India's only manufacturer), hexylene glycol and meta xylenol.
4. Objects of the Issue
The Offer comprises a fresh issue aggregating up to Rs.80 crore plus an offer for sale aggregating up to Rs.420 crore by the Selling Shareholders (OFS proceeds do not accrue to the Company).
Of the fresh issue net proceeds, Rs.60 crore is earmarked for repayment/prepayment of the Company's outstanding borrowings, with the balance (capped at 25% of gross proceeds) for general corporate purposes, to be deployed within Fiscal 2027.
Notably, the OFS component (Rs.420 crore) is more than five times the size of the fresh issue (Rs.80 crore) meaning the substantial majority of this Rs.500 crore offer represents existing shareholders monetizing their holdings, with only a modest amount of fresh capital actually being raised for the Company's own balance-sheet needs.
5. Key Investment Highlights
- Highly diversified specialty chemical portfolio (150+ products) across multiple application industries, insulating the Company from disruption in any single end-market.
- India's largest acetone importer (CY2022-2025) and sole domestic manufacturer of isophorone, alongside a top-5 position among domestic yellow phosphorous users.
- Well-established R&D capabilities with a dedicated facility, 37-member team, and a 40-product development pipeline supporting continuous innovation.
- Long-standing relationships with a diversified, growing customer base (1,618 customers in FY26) and strong global presence across 69 export countries.
- Limited domestic competition in acetone-based specialty chemicals, given the scarcity of comparable Indian manufacturers, versus a broader field of established global competitors.
6. Brief Financial Performance & Metrics
**Not Annualized
| Particulars |
2024 (in crores) |
2025 (in crores) |
2026 (in crores) |
| Total Income |
887.56 |
1,015.54 |
1,237.85 |
| Total Expenditure |
848.28 |
956.25 |
1,125.95 |
| EBITDA |
60.53 |
87.77 |
139.32 |
| Profit Before Tax (PBT) |
33.51 |
59.29 |
111.90 |
| Profit After Tax (PAT) |
18.13 |
43.57 |
83.12 |
| E.P.S. (Diluted) (Rs.) |
3.13 |
7.51 |
14.33 |
| RONW (%) |
5.56% |
11.86% |
18.53% |
7. IPO Timeline & Payment Charts
Indicative Time Table
| Tentative Events |
Indicative Dates |
| Finalisation of Basis of Allotment with the Designated Stock Exchange |
11/9/2026 |
| Initiation of refunds/unblocking ASBA Fund |
15/9/2026 |
| Credit of Equity Shares to demat accounts of Allottees |
15/9/2026 |
| Commencement of trading of the Equity Shares on the Stock Exchanges |
16/9/2026 |
Price Chart (@ 676) (Retail Category)
| LOT SIZE (Shares) |
Amount (Rs.) |
| 22 | 14,872 |
| 44 | 29,744 |
| 66 | 44,616 |
| 88 | 59,488 |
| 110 | 74,360 |
| 132 | 89,232 |
| 154 | 1,04,104 |
| 176 | 1,18,976 |
| 198 | 1,33,848 |
| 220 | 1,48,720 |
| 242 | 1,63,592 |
| 264 | 1,78,464 |
| 286 | 1,93,336 |
HNI Payment Chart
| Category |
No. of Shares |
Minimum Bid Lot Amount (Rs.) |
| Small HNI |
308 |
2,08,208 |
| Big HNI |
1,496 |
10,11,296 |
8. Our View / Recommendation
Analyst Recommendation: SUBSCRIBE
Sushil Finance Research Stance & Valuation View
Prasol Chemicals merits a Subscribe, anchored in a genuinely accelerating growth and profitability trajectory. Total income grew from Rs.1,015.54 crore to Rs.1,237.85 crore in FY26 (21.9% YoY), while PAT nearly doubled from Rs.43.57 crore to Rs.83.12 crore (90.7% growth) profit compounding far faster than revenue, evidencing genuine operating leverage as EBITDA margin expanded from 8.64% to 11.25%.
RoNW has climbed sharply and consistently across all three years from 5.56% to 11.86% to 18.53% a clean, uninterrupted improvement in capital efficiency, a strong trend in recent IPOs.
The Company's category positioning is genuinely differentiated: sole domestic manufacturer of isophorone, India's largest acetone importer, and limited direct domestic competition in acetone-based specialty chemicals, giving it a strong pricing power and being structurally protected.
9. Frequently Asked Questions (FAQs)
Q1. What is the business profile and industry experience of Prasol Chemicals Limited?
Incorporated in 1992, Prasol Chemicals is a forward-integrated manufacturer of acetone- and phosphorous-based specialty chemicals with over 33 years of experience. It produces over 150 products across acetone-based, phosphorous-based, and other specialty categories.
Q2. What is Prasol Chemicals' market standing in acetone and isophorone?
Prasol Chemicals was India's largest importer of acetone (CY2022-2025) and is the only manufacturer of isophorone in India, alongside being in the top-5 among domestic yellow phosphorous users.
Q3. What are the key IPO dates and price band for Prasol Chemicals?
The IPO opens on September 8, 2026, and closes on September 10, 2026. The price band is ₹643 to ₹676 per equity share, with a minimum retail bid lot of 22 shares (₹14,872 at upper band).
Q4. How will the IPO fresh proceeds be deployed?
Out of the ₹80 crore fresh issue net proceeds, ₹60 crore will be utilized for repayment/prepayment of outstanding borrowings, and the balance (capped at 25% of gross proceeds) will be deployed for general corporate purposes in Fiscal 2027.
Q5. What is the analyst recommendation on Prasol Chemicals IPO?
Sushil Finance assigns a "Subscribe" recommendation based on strong operating leverage, PAT doubling in FY26 to ₹83.12 crore, EBITDA margin expansion to 11.25%, continuous RoNW growth to 18.53%, and structural competitive moats.
10. Red Herring Prospectus (RHP) Reference
11. Disclaimer
The content provided in this blog is for informational and educational purposes only and should not be construed as investment, legal, or tax advice. While Sushil Finance makes reasonable efforts to ensure accuracy and reliability of the information, we do not guarantee its completeness or timeliness. Readers are advised to consult with their financial advisor before making any investment decisions. Sushil Finance shall not be held responsible for any direct or indirect loss arising from use of this content. Investments in securities are subject to market risks. Read all scheme-related documents carefully before investing.
